BusinessIlluminOss Medical Granted FDA Marketing Clearance for the IlluminOss® Bone Stabilization SystemBy Nasdaq OMXJan 9, 2018, 2:01 PM UTC
BusinessBioCorRx Selects Covance for Non-Clinical Studies, Announces the Addition of Dr. Bal S. Brar to its Drug Development Team, Plans Pre-IND Meeting with FDABy Nasdaq OMXNov 28, 2016, 11:00 AM UTC
Businessbiotricity Receives an FDA 510(k) Clearance – Marks Major Milestone in Path to CommercializationBy Nasdaq OMXOct 18, 2016, 12:01 PM UTC
Businessbiotricity Receives an FDA 510(k) Clearance – Marks Major Milestone in Path to CommercializationBy Nasdaq OMXOct 18, 2016, 12:01 PM UTC
